Medpace Holdings, Inc. - Common Stock (MEDP) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MEDP on Nasdaq
Shares outstanding
28,414,670
Price per share
$602.06
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
23,738,196
Total reported value
$13,332,152,110
% of total 13F portfolios
0.01%
Share change
-134,472
Value change
-$57,438,386
Number of holders
768
Price from insider filings
$602.06
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medpace Holdings, Inc. - Common Stock (MEDP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Troendle August J. 20% +2.5% $3,389,756,472 -$200,043,884 5,682,934 -5.6% August J. Troendle 26 Nov 2025

As of 31 Dec 2025, 768 institutional investors reported holding 23,738,196 shares of Medpace Holdings, Inc. - Common Stock (MEDP). This represents 84% of the company’s total 28,414,670 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Medpace Holdings, Inc. - Common Stock (MEDP) together control 51% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.5% 2,412,617 +2.4% 0.02% $1,355,046,473
VANGUARD GROUP INC 8% 2,261,848 -0.93% 0.02% $1,270,366,929
AQR CAPITAL MANAGEMENT LLC 4.8% 1,349,703 +32% 0.4% $758,060,688
GEODE CAPITAL MANAGEMENT, LLC 2.3% 667,298 +3.8% 0.02% $374,836,410
STATE STREET CORP 2.3% 664,893 -1.2% 0.01% $373,437,153
WASATCH ADVISORS LP 2.3% 648,306 -30% 2.2% $364,121,065
BAILLIE GIFFORD & CO 1.9% 547,078 -6.4% 0.26% $307,266,359
D. E. Shaw & Co., Inc. 1.9% 528,232 -12% 0.23% $296,681,502
Invesco Ltd. 1.7% 482,625 -10% 0.04% $271,066,333
RENAISSANCE TECHNOLOGIES LLC 1.6% 465,908 -5.6% 0.41% $261,677,228
MORGAN STANLEY 1.5% 416,678 -18% 0.01% $234,028,215
Mawer Investment Management Ltd. 1.4% 407,302 -37% 1.3% $228,761,168
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.3% 375,033 +19% 0.12% $210,637,284
DIMENSIONAL FUND ADVISORS LP 1.3% 359,350 -7.4% 0.04% $201,842,484
GOLDMAN SACHS GROUP INC 1.2% 347,049 +92% 0.03% $194,920,071
UBS Group AG 1.2% 328,879 +33% 0.04% $184,714,890
BESSEMER GROUP INC 1.1% 317,040 -7.3% 0.27% $178,066,000
FRANKLIN RESOURCES INC 1.1% 299,472 +159% 0.04% $168,198,449
Madison Asset Management, LLC 0.98% 277,757 -5.1% 1.8% $156,002,444
RIVERBRIDGE PARTNERS LLC 0.96% 272,969 -25% 2.9% $153,313,207
Giverny Capital Inc. 0.93% 263,320 +0.58% 4.9% $147,893,678
AMERICAN CAPITAL MANAGEMENT INC 0.79% 224,374 -9.8% 5.6% $126,019,657
NORTHERN TRUST CORP 0.77% 218,913 -9.7% 0.02% $122,952,486
BANK OF AMERICA CORP /DE/ 0.74% 210,696 -8.1% 0.01% $118,337,408
Clearbridge Investments, LLC 0.72% 205,182 -20% 0.09% $115,240,555

Institutional Holders of Medpace Holdings, Inc. - Common Stock (MEDP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 23,738,196 $13,332,152,110 -$57,438,386 $561.65 768
2025 Q3 23,972,493 $12,317,346,300 -$1,131,542,576 $514.16 668
2025 Q2 26,383,560 $8,288,435,409 +$333,924,731 $313.86 594
2025 Q1 25,351,494 $7,718,802,423 -$9,540,540 $304.69 578
2024 Q4 25,340,363 $8,420,105,198 +$2,781,687 $332.23 584
2024 Q3 25,315,006 $8,458,156,137 -$55,147,913 $333.80 577
2024 Q2 25,134,495 $10,351,346,830 -$31,621,959 $411.85 617
2024 Q1 25,247,742 $10,201,457,017 +$309,719,146 $404.15 585
2023 Q4 24,605,167 $7,542,681,992 +$229,825,667 $306.53 537
2023 Q3 23,978,527 $5,807,458,403 -$1,302,082 $242.13 482
2023 Q2 23,852,532 $5,728,812,297 -$189,263,357 $240.17 457
2023 Q1 24,865,090 $4,674,846,132 +$108,498,439 $188.05 412
2022 Q4 24,347,700 $5,172,004,976 -$300,121,456 $212.41 415
2022 Q3 25,865,491 $4,065,022,806 -$87,591,355 $157.17 341
2022 Q2 26,319,125 $3,938,916,557 -$138,934,775 $149.67 328
2022 Q1 27,353,541 $4,474,335,613 -$288,675,997 $163.59 336
2021 Q4 28,637,675 $6,230,873,750 -$17,998,983 $217.64 378
2021 Q3 28,619,666 $5,416,650,219 +$197,797,063 $189.28 330
2021 Q2 27,593,763 $4,873,907,764 -$68,366,795 $176.63 319
2021 Q1 27,985,360 $4,594,004,259 +$104,275,194 $164.05 312
2020 Q4 27,673,447 $3,850,051,602 +$93,810,402 $139.20 307
2020 Q3 27,120,457 $3,030,671,185 -$135,168,695 $111.75 304
2020 Q2 28,380,989 $2,639,244,485 +$14,303,231 $93.02 267
2020 Q1 28,430,389 $2,087,064,779 -$34,301,689 $73.38 262
2019 Q4 28,848,283 $2,419,068,792 +$10,252,483 $84.06 245
2019 Q3 28,714,636 $2,408,420,205 -$89,388,643 $84.04 261
2019 Q2 29,995,588 $1,944,530,366 +$211,380,396 $65.42 218
2019 Q1 27,512,201 $1,621,089,764 -$96,482,454 $58.97 227
2018 Q4 29,281,202 $1,538,952,893 +$254,103,472 $52.93 214
2018 Q3 24,153,990 $1,447,749,021 +$617,515,363 $59.91 207
2018 Q2 13,950,730 $599,818,408 +$188,465,083 $43.00 143
2018 Q1 9,597,152 $335,058,130 +$32,462,085 $34.91 110
2017 Q4 8,576,307 $311,077,359 +$80,900,389 $36.26 114
2017 Q3 6,398,882 $204,099,830 +$6,836,884 $31.90 86
2017 Q2 6,311,396 $183,034,029 -$10,975,727 $29.00 79
2017 Q1 6,619,292 $197,596,759 -$7,556,903 $29.85 77
2016 Q4 7,258,548 $261,798,100 +$44,435,837 $36.07 79
2016 Q3 6,172,151 $184,306,689 +$184,306,689 $29.86 68